drugset / Trial / NCT01247272
90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
This study compared the relative bioavailability (rate and extent of absorption) of 90 mg Fluoxetine Hydrochloride Capsules by Teva Pharmaceuticals, USA with that of 90 mg PROZAC WEEKLY® Capsules by Eli Lilly and Company following a single oral dose (1 x 90 mg) in healthy adult volunteers under fasting conditions.
Timeline
- Start
- 2001-05
- Primary completion
- 2001-07
- Completion
- 2001-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | 90 mg | Oral |
Indications
No indication recorded.